Skip to main content
Premium Trial:

Request an Annual Quote

Millennium Predictive Medicine Appointments

Premium

CAMBRIDGE, Mass.--John Unger was appointed chief scientific officer and Robert Schlegel director of genomics at Millennium Predic tive Medicine (MPM). Unger joins the company--a wholly owned subsidiary of Millennium Pharmaceu ticals--with over 20 years of experience in medical diagnostics. He will lead MPM's effort to build a diagnostics and pharmacogenomics research organization. Previously, he was executive director, new technology research, at Chiron Diagnostics in Medfield, Mass. Schlegel will lead the company's genomics effort in the areas of oncology and chemoprediction. He also came to Millenni um from Chiron, where he headed genomics research. He remains an adjunct associate professor at the Harvard School of Public Health, department of cancer cell biology where he was a full time faculty member for nine years.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.